ARCH VENTURE PARTNERS XII, LLC purchased 1.3% of their position (170K shares) of CITY THERAPEUTICS, INC. on the open market
Open‑market purchase worth $3.06M — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+3.29M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+5.48M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.03M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+170K
Price / share
$18.00
Trade value
$3.06M
% of position
Net shares
+10.97M
Net value
$3.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/19/2026 | C · Conversion | +3.29M | — | — | 121.2% | 2.72M | 6.01M |
| Common Stock Indirect | 10/19/2026 | C · Conversion | +5.48M | — | — | 91.2% | 6.01M | 11.50M |
| Common Stock Indirect | 10/19/2026 | C · Conversion | +2.03M | — | — | 17.6% | 11.50M | 13.52M |
| Common Stock Indirect | 10/19/2026 | P · Purchase | +170K | $18.00 | $3.06M | 1.3% | 13.52M | 13.69M |
| Total | +10.97M | $3.06M | ||||||
Series Seed convertible preferred stock
Common Stock
3.29M shares
Shares
−3M
Strike price
Held after
0.00
Exercisable
—
Series A convertible preferred stock
Common Stock
5.48M shares
Shares
−4.99M
Strike price
Held after
0.00
Exercisable
—
Series B convertible preferred stock
Common Stock
2.03M shares
Shares
−1.85M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series Seed convertible preferred stock Indirect | Common Stock3.29M shares | 10/19/2026 | C · Conversion | −3M | — | 0.00 | |
| Series A convertible preferred stock Indirect | Common Stock5.48M shares | 10/19/2026 | C · Conversion | −4.99M | — | 0.00 | |
| Series B convertible preferred stock Indirect | Common Stock2.03M shares | 10/19/2026 | C · Conversion | −1.85M | — | 0.00 |